//Краткое руководство по ведению пациентов с онкологическими заболеваниями мочеполовой системы


Palou J. et al. Multivariate analysis of clinical parameters of synchronous primary superficial bladder cancer and upper urinary tract tumor. J Urol. 2005;174:859. https://www.ncbi.nlm.nih.gov/pubmed/16093970.

Yafi F.A. et al. Prospective analysis of sensitivity and specificity of urinary cytology and other urinary biomarkers for bladder cancer. Urol Oncol. 2015;33:66e25. https://www.ncbi.nlm.nih.gov/pubmed/25037483.

Tetu B. Diagnosis of urothelial carcinoma from urine. Mod Pathol. 2009;22 Suppl 2:S53. https://www.ncbi.nlm.nih.gov/pubmed/19494853.

Kurth K.H. et al. Current methods of assessing and treating carcinoma in situ of the bladder with or without involvement of the prostatic urethra. Int J Urol. 1995;2 Suppl 2:8. https://www.ncbi.nlm.nih.gov/pubmed/7553309.

Richterstetter M. et al. The value of extended transurethral resection of bladder tumour (TURBT) in the treatment of bladder cancer. BJU Int. 2012;110:E76. https://www.ncbi.nlm.nih.gov/pubmed/22313727.

Kramer M.W. et al. En bloc resection of urothelium carcinoma of the bladder (EBRUC): a European multicenter study to compare safety, efficacy, and outcome of laser and electrical en bloc transurethral resection of bladder tumor. World J Urol. 2015;33:1937. https://www.ncbi.nlm.nih.gov/pubmed/25910478.

Mariappan P. et al. Detrusor muscle in the first, apparently complete transurethral resection of bladder tumour specimen is a surrogate marker of resection quality, predicts risk of early recurrence, and is dependent on operator experience. Eur Urol. 2010;57:843. https://www.ncbi.nlm.nih.gov/pubmed/19524354.

Gupta N.P. et al. Bipolar energy for transurethral resection of bladder tumours at low-power settings: initial experience. BJU Int. 2011;108:553. https://www.ncbi.nlm.nih.gov/pubmed/21176081.

Hara T. et al. Risk of concomitant carcinoma in situ determining biopsy candidates among primary non-muscle-invasive bladder cancer patients: retrospective analysis of 173 Japanese cases. Int J Urol. 2009;16:293. https://www.ncbi.nlm.nih.gov/pubmed/19207607.

//Краткое руководство по ведению пациентов с онкологическими заболеваниями мочеполовой системы


Palou J. et al. Female gender and carcinoma in situ in the prostatic urethra are prognostic factors for recurrence, progression, and disease-specific mortality in T1G3 bladder cancer patients treated with bacillus Calmette-Guerin. Eur Urol. 2012;62:118. https://www.ncbi.nlm.nih.gov/pubmed/22101115.

Kausch I. et al. Photodynamic diagnosis in non-muscle-invasive bladder cancer: a systematic review and cumulative analysis of prospective studies. Eur Urol. 2010;57:595. https://www.ncbi.nlm.nih.gov/pubmed/20004052.

Grimm M.O. et al. Effect of routine repeat transurethral resection for superficial bladder cancer: a long-term observational study. J Urol. 2003;170:433. https://www.ncbi.nlm.nih.gov/pubmed/12853793.

Angulo J.C. et al. Second transurethral resection and prognosis of high-grade non-muscle invasive bladder cancer in patients not receiving bacillus Calmette-Guerin. Actas Urol Esp. 2014;38:164. https://www.ncbi.nlm.nih.gov/pubmed/24613147.

Baltaci S. et al. Significance of the interval between first and second transurethral resection on recurrence and progression rates in patients with high-risk non-muscle-invasive bladder cancer treated with maintenance intravesical Bacillus Calmette-Guerin. BJU Int. 2015;116:721. https://www.ncbi.nlm.nih.gov/pubmed/25715815.

Sylvester R.J. et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol. 2006;49:466. https://www.ncbi.nlm.nih.gov/pubmed/16442208.

Brausi M. et al. Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies. Eur Urol. 2002;41:523. https://www.ncbi.nlm.nih.gov/pubmed/12074794.

Soloway M.S. et al. Urothelial susceptibility to tumor cell implantation: influence of cauterization. Cancer. 1980;46:1158. https://www.ncbi.nlm.nih.gov/pubmed/7214299.